About Armata Pharmaceuticals
Armata Pharmaceuticals is a company based in Los Angeles (United States) founded in 1989.. The company has 60 employees as of December 31, 2024. Armata Pharmaceuticals offers products and services including Bacteriophages, Synthetic Phage Platform, and AP-PA02 & AP-PA03. Armata Pharmaceuticals operates in a competitive market with competitors including Spero Therapeutics, Nabriva, Melinta Therapeutics, Iterum Therapeutics and BiomX, among others.
- Headquarter Los Angeles, United States
- Employees 60 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Armata Pharmaceuticals, Inc.
-
Annual Revenue
$5.17 M14.24as on Dec 31, 2024
-
Net Profit
$-18.92 M72.6as on Dec 31, 2024
-
EBITDA
$-41.11 M-2.99as on Dec 31, 2024
-
Latest Funding Round
$26.9 M (USD), Post-IPO
Apr 01, 2022
-
Investors
Cystic Fibrosis Foundation
& 2 more
-
Employee Count
60
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Armata Pharmaceuticals
Armata Pharmaceuticals is a publicly listed company on the AMEX with ticker symbol ARMP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Armata Pharmaceuticals
Armata Pharmaceuticals offers a comprehensive portfolio of products and services, including Bacteriophages, Synthetic Phage Platform, and AP-PA02 & AP-PA03. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Phage-based treatments targeting bacterial infections.
Platform for developing advanced phage therapeutics.
Clinical programs for specific phage therapeutics.
Unlock access to complete
Unlock access to complete
Funding Insights of Armata Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $26.9M
-
First Round
First Round
(15 Sep 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Post-IPO - Armata Pharmaceuticals | Valuation |
investors |
|
| Feb, 2022 | Amount | Post-IPO - Armata Pharmaceuticals | Valuation |
investors |
|
| Oct, 2021 | Amount | Post-IPO - Armata Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Armata Pharmaceuticals
Armata Pharmaceuticals has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Cystic Fibrosis Foundation, Innoviva and Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Respiratory prescription drugs are developed and in-licensed for COPD treatment.
|
Founded Year | Domain | Location | |
|
Research funding and support for cystic fibrosis patients are provided.
|
Founded Year | Domain | Location | |
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Armata Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Armata Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Armata Pharmaceuticals Comparisons
Competitors of Armata Pharmaceuticals
Armata Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Spero Therapeutics, Nabriva, Melinta Therapeutics, Iterum Therapeutics and BiomX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for drug-resistant bacterial infections are developed.
|
|
| domain | founded_year | HQ Location |
Pleuromutilin antibiotics are developed for MDR infections.
|
|
| domain | founded_year | HQ Location |
Developer of bacterial ribosome-targeting drugs for MDR infections
|
|
| domain | founded_year | HQ Location |
Developer of antibiotics for MDR infections
|
|
| domain | founded_year | HQ Location |
Microbiome therapeutics are developed for dysbiosis-linked diseases.
|
|
| domain | founded_year | HQ Location |
Therapies for multi-drug resistant infections are developed using bacteriophages.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Armata Pharmaceuticals
Frequently Asked Questions about Armata Pharmaceuticals
When was Armata Pharmaceuticals founded?
Armata Pharmaceuticals was founded in 1989 and raised its 1st funding round 19 years after it was founded.
Where is Armata Pharmaceuticals located?
Armata Pharmaceuticals is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Who is the current CEO of Armata Pharmaceuticals?
Deborah L Birx is the current CEO of Armata Pharmaceuticals.
How many employees does Armata Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Armata Pharmaceuticals is 60.
What is the annual revenue of Armata Pharmaceuticals?
Annual revenue of Armata Pharmaceuticals is $5.17M as on Dec 31, 2024.
What does Armata Pharmaceuticals do?
Armata Pharmaceuticals was founded in 1989 in Los Angeles, United States, within the biotechnology sector. Phage therapeutics are developed by the company to address key antibiotic-resistant bacteria. The lead candidate, AP-SA01, is targeted at Staphylococcus aureus, including multidrug-resistant strains. A pipeline of proprietary synthetic phage candidates is also advanced, such as one for Pseudomonas aeruginosa. Operations focus on therapeutic development for infectious diseases.
Who are the top competitors of Armata Pharmaceuticals?
Armata Pharmaceuticals's top competitors include Spero Therapeutics, Melinta Therapeutics and Vedanta Biosciences.
What products or services does Armata Pharmaceuticals offer?
Armata Pharmaceuticals offers Bacteriophages, Synthetic Phage Platform, and AP-PA02 & AP-PA03.
Is Armata Pharmaceuticals publicly traded?
Yes, Armata Pharmaceuticals is publicly traded on AMEX under the ticker symbol ARMP.
Who are Armata Pharmaceuticals's investors?
Armata Pharmaceuticals has 3 investors. Key investors include Cystic Fibrosis Foundation, Innoviva, and Military Health.
What is Armata Pharmaceuticals's ticker symbol?
The ticker symbol of Armata Pharmaceuticals is ARMP on AMEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.